Generics Bulletin is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Elizabeth Orr

Managing Editor, Policy & Regulation

Washington, DC

Elizabeth leads a team of Medtech Insight reporters devoted to covering medical device and diagnostics regulation in the US and abroad. As a reporter, she focuses on FDA regulation, legislation, and legal issues. A graduate of the University of Maryland College Park, she worked for outlets including FDA News, DecisionHealth (formerly UCG) and the Washington Examiner before joining Medtech Insight in 2015. She lives in Arlington, VA, with her husband and children.

Latest From Elizabeth Orr

It’s A Class I Recall For Baxter’s WatchCare Device

Radiofrequencies from the incontinence-sensing devices may interfere with other medical equipment in a hospital setting. 

Recalls Regulation

It’s A Class I Recall For Baxter’s WatchCare Device

Radiofrequencies from the incontinence-sensing devices may interfere with other medical equipment in a hospital setting. 

Recalls Regulation

Ex-Theranos CEO Elizabeth Holmes Sentenced To 11-Year Prison Term

The former diagnostics company executive was convicted in January on four counts of fraud.

Legal Issues Policy

Roche Wins FDA Authorization On High-Volume Monkeypox Test

The test, which is the first for the condition to win an EUA using actual patient samples, provides results in about three and a half hours. 

Approvals FDA

Philips Admits New Issues In Reworked Ventilators

A silicone foam that replaced hazardous polyurethane in some reworked Philips Trilogy ventilators could separate from the unit and block air flow; additionally, particles have been found in ventilator air pathways. 

Recalls Regulation

FDA: Insulet Omnipod DASH Recall Deemed Class I

Batteries used in the diabetes management devices may leak fluids or overheat, posing a potential fire risk. The recall, which the US FDA has now announced qualifies as high-risk class I, was first announced in October.

Recalls Regulation
See All
UsernamePublicRestriction

Register